Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback